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Summary 
Interferon "), (IFN-v), a lymphokine that exerts multiple immunoregulatory effects, has been 
found to be elevated in the plasma, cerebrospinal fluid, and lymph nodes of human immunoddldency 
virus (HIV)-infected individuals and has shown variable effects on HIV replication in acutely 
infected cells. In the present study, we have demonstrated that IFN-v is a potent modulator 
of HIV expression in persistently infected U1 promonocytic cells in which virus production is 
characterized by a constitutive state of relative latency. Direct stimulation of U1 cells with IFN-'), 
(10-1,000  U/m1) activated HIV expression,  as measured by reverse transcriptase  (RT) activity 
in the culture supernatant and increased levels of cell-associated viral protein and mRNAs. These 
effects on virus expression were not accounted for by the induction of endogenous TNF-cr secretion, 
as previously described in U1 cells stimulated with phorbol myristate acetate  (PMA). At the 
ultrastructural  level, the stimulatory activity of IFN-v was correlated with HIV particle production 
in intracytoplasmic vacuoles along with the differentiation of U1 into macrophage-like cells. 
Furthermore,  costimulation of U1  cells  with  IFN-v  and  PMA  significantly increased  the 
accumulation of vacuole-associated  HIV concomitant with decreasing membrane-associated particles 
and RT activity production, as compared with cells stimulated with PMA alone. No evidence 
of spontaneous secretion of intracellular vacuole-associated virus was obtained by kinetic analysis 
of the RT activity released in the supernatants throughout the culture period unless cells were 
deliberately  disrupted, These findings suggest that vacuole-associated virions likely represent a 
relatively stable intracellular reservoir of HIV, as previously described in primary macrophages 
infected in vitro or in infected macrophages in the brains  of patients with acquired immune 
deficiency syndrome. The reduced levels of RT activity observed in the culture supernatants of 
U1 cells stimulated with PMA in the presence of IFN-3' were not indicative of a suppressive 
effect of IFN-3' on PMA-induced expression of HIV proteins and mRNAs, either directly or 
mediated by the release of IFN-od/3.  This study suggests that IFN-3' may play an important 
role as an inducer of HIV expression  in infected mononuclear phagocytes. 
I 
'FN-3' is a potent lymphokine  produced by activated T cells 
. that mediates several immunomodulatory  and antimicrobial 
effects (reviewed in references 1-4). Both in vivo and in vitro 
studies have previously investigated the potential role of IFN-3' 
in HIV infection. Elevated levels of IFN-3' and/or of the IFN- 
"),-inducible factor neopterin have been found in the plasma 
and cerebrospinal fluid (CSF) 1 of HIV-infected individuals at 
various stages of disease (5-7). In contrast, PBMC from HIV- 
1 Abbreviations used in this paper: CSF, cerebrospinal  fluid; MDM. mono- 
cyte-derived  macrophages;  MP,  mononuclear  phagocytes;  RT,  reverse 
transcriptase. 
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impaired ability to generate IFN-3, in vitro (8-10), although 
purified subpopulations of T cells showed an intact capacity 
to secrete this lymphokine (11). High levels of IFN-~ RNA 
were recently demonstrated in  the lymph nodes of HIV- 
infected individuals (12),  suggesting that this lymphokine 
may influence the ability of HIV to replicate in CD4 + T 
lymphocytes and mononuclear phagocytes (MP) in vivo. 
In vitro, IFN-o~ and IFN-fl, but not IFN-% inhibited HIV 
replication in mitogen-stimulated PBMC (13) in which IFN-3" 
may actually act as an endogenous autocrine/paracrine in- 
ducer of HIV replication in conjunction with TNF-oUfl (14). 
In other studies, the combination of IFN-3' and TNF-ol has 
been reported to induce cytolysis of HIV-infected cell lines 
but not of their uninfected counterparts, in association with 
a reduction of viral RNA (15). In addition, IFN-3' showed 
suppressive  effects on HIV replication in certain T cell lines 
(16) and in the promonocytic cell line U937 (17, 18), which 
were acutely infected with HIV. In primary human monocyte- 
derived macrophages (MDM), IFN-ol, -fl, and -3' suppressed 
HIV replication when added to culture either before or up 
to 3 d after infection (19). However, other investigators have 
observed dichotomous effects of IFN-3, on virus replication 
in MDM, in that inhibition of virus expression was seen in 
cells pretreated with this lymphokine, whereas upregulation 
of p24 Ag production occurred if cells were treated with IFN-3, 
after infection (20).  These studies suggest that IFN-3, may 
play different and even opposite roles in the regulation of HIV 
replication in different cell types. However, little or no infor- 
mation is available on the effects of IFN-3, in cells persis- 
tently infected with HIV. In this regard, several in vivo and 
in vitro studies have underscored the importance of persis- 
tent HIV infection in the pathogenesis of AIDS (21). Quan- 
titative studies have demonstrated that in the peripheral blood 
compartment the number of infected cells that are in a state 
of either relative or absolute viral latency exceeds by about 
10-fold  the number of cells actively expressing HIV RNA 
or proteins (22).  Most of these circulating infected cells are 
CD4 + T lymphocytes, whereas monocytes in the peripheral 
blood are infrequent targets of HIV infection in vivo (22-24). 
In contrast, terminally differentiated macrophages represent 
a major viral reservoir in several tissues and organs, including 
the brain (25, 26) and the lungs (27) of HIV-infected indi- 
viduals, and have been found to express high levels of viral 
ILNA (25,  26). One distinctive aspect of HIV infection in 
macrophages is the ability of the virus to bud from and ac- 
cumulate into intracellular vacuolar compartments (28-32), 
an uncommon feature in infected T  lymphocytes. This ob- 
servation, coupled with the lower susceptibility of MP to 
the cytocidal effects of HIV (23, 28), has suggested that tissue 
macrophages may represent important viral reservoirs that 
play a major role in the establishment of a state of chronic 
infection typical of most infected individuals (21, 32). There- 
fore,  understanding whether physiologic host  factors can 
influence the ability of HIV to assemble and accumulate in 
intracellular compartments as opposed to the plasma mem- 
brane of infected macrophages may be of importance for 
designing therapeutic strategies targeting HIV at its different 
cellular and sub-cellular sites of expression. In this regard, 
it has been reported that IFN-ot effectively suppressed the 
release of HIV particles from the plasma membrane of chron- 
ically infected T  lymphocytic cells (33-35),  a phenomenon 
that had been already described in cells persistently infected 
with other retroviruses after treatment with IFNs (36). 
In the present study, we have investigated the effect of IFNw 
on the chronically infected promonocytic cell line U1, in which 
virus expression is modulated by several cytokines and phar- 
macologic agents (reviewed in references 21 and 37). PMA 
stimulation of U1 cells not only induces HIV production, 
but also induces the terminal differentiation of these cells along 
the mononuclear phagocytic lineage in association with the 
accumulation of HIV particles in Golgi-derived intracellular 
vacuoles (38), as described in primary infected macrophages 
(28-32). Thus, we determined the effects of INF-3, alone or 
in costimulation with PMA on cellular morphology, virus 
production,  and virion compartmentalization in U1 cells. 
Materials and Materials 
Chronically HIV-infected Cell Lines.  The U1 cell line was estab- 
lished from a population of U937 promonocytic cells surviving an 
acute infection with HIV-1, as described previously in detail (38). 
U1 cells contain two integrated copies of HIV proviral DNA, and 
are characterized by low levels of constitutive virus expression that 
can be modulated by several cytokines and pharmacologic agents 
(21, 37-40).  1-2  x  10  s U1 cells/ml were resuspended in RPMI 
1640 (M.A. Whitaker Bioproducts, Walkersville, ME)) containing 
10% FCS, plated in 96-well flat-bottomed plates (Costar, Cam- 
bridge, MA), and incubated with either rlFNq, (Genzyme, Boston, 
MA), rlFN-uzB (Schering, Kenilworth, NJ), rlFN-fl (kind gift of 
Dr. Sidney  Petska, UMDNJ, Robert Wood Johnson Medical  School, 
Piscataway, NJ), PMA (10 -7 to 10 -s M) (Sigma Chemical Co., St. 
Louis, MO), rTNF-c~, or ffNF-fl (100 U/ml) (Genzyme), at 37~ 
in 5% CO2. Supernatants from the cell cultures were collected at 
various times after stimulation and stored at  -70~  until tested 
for the presence of reverse transcriptase (RT)  activity. 
RT Activity Assay.  5/~1  of culture supematants was added in 
duplicate or triplicate to 25/~1 of a mixture containing poly(A), 
oligo(dT)  (Pharmacia Fine Chemicals, Piscataway, NJ), MgCI~, 
and [32P]-labeled  deoxythymidine 5'-triphosphate (dTTP) (Amer- 
sham Corp., Arlington Heights, IL), and incubated for 2 h at 37~ 
6/~1 of the mixture was spotted onto DE81 paper, air-dried, washed 
five times in 2x SSC buffer, and two additional times in 95% eth- 
anol. The paper was then dried, cut, and counted on a scintillation 
counter (IS 7000; Beckman Instruments, Inc., Fullerton, CA). Vari- 
ability of replicate cultures was always <15%. 
Western Blot Analysis of Cell-associated HIV Pro~'ns.  Lysates  were 
prepared from U1 cells either unstimulated or stimulated for 48 h 
with IFN-3' (1,000 U/ml), PMA (10 -8 M), or costimulated with 
IFN-7 plus PMA. 20/~1 from the lysate of 107 cells was added to 
each lane and subjected to electrophoresis through 10-20%  gra- 
dient polyacrylamide gels (Integration Sep. Sci., Hyde Park, MA) 
for 6 h. The migrated proteins were then transferred overnight onto 
nitrocellulose filters. After saturation with a 5%  milk solution, 
filters were incubated for 2 h with 1:1,000 (vol/vol) dilution  of 
an AIDS patient serum containing high titers of anti-HIV Ab recog- 
nizing most of the major viral proteins (33). Filters  were then washed 
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dpm/ml), washed, air-dried, and exposed overnight to x-ray film. 
Analysis ofHIV RNA.  U1 cells were either unstimulated, or 
stimulated for 24 h with IFN-y (1,000 U/ml), TNF-~x (100 U/ml), 
and PMA (10-7 M), or costimulated with PMA plus IFN-7. Total 
RNA was extracted from 2  x  107 U1 cells by the guanidine thio- 
cyanate phenol method using an RNA isolation kit (Stratagene, 
LaJolla, CA). In some experients, different amounts of RNA were 
transferred to nitrocellulose filters in an RNA slot blot Minifold 
II apparatus (Schleicher  & Schuell, Inc., Keene, NH), and the filters 
were hybridized overnight with a 32p labeled 6.4-kb DNA probe 
(pBenn 5; map position, 1.7-8.1 kb), washed, and exposed to x-ray 
film as described (41). For Northern  blot analysis, 10 t~g of total 
RNA extracted at different times after stimulation was loaded per 
lane on a 0.8% agarose  formaldehyde  gel and transferred  to nitrocel- 
lulose. The filters were baked and hybridized for 12 h with a 32p 
labeled HIV-LTR homologous probe (SST-BssHII). Filters were 
washed and exposed to x-ray film. The labded probe was removed 
from the filters by washing at 80~  in 0.1x  SSC containing 0.1% 
SDS; the filters were then rehybridized with a 32p labeled fl-actin 
eDNA probe, as previously described (42). 
Ultrastructural Studies.  U1  cells were stimulated with either 
IFN-cx (20-100 U/m1), IFN-fl  (100 U/ml),  IFN-'y (100-1,000 
U/ml), PMA (10 -s M), or costimulated with IFN-ot and PMA, 
IFN-fl and PMA, or IFN-y and PMA for 36-120 h. Cells were 
spun, fixed in glutaraldehyde, and then postfixed in OsO4, de- 
hydrated in graded ethanol and propylene oxide, and embedded in 
plastic, as described (33). For each sample, 100 consecutive  cell sec- 
tions were screened for the presence and location of HIV. Only 
sections at or close to the center of  the cell and Golgi compartment 
(based on known average size of cell and nucleus) were included 
for evaluation. The findings were tallied as percentage of  cells with 
HIV budding from or intimately associated  with the plasma mem- 
brane only, HIV present in cytoplasmic  vacuoles only, or HIV ob- 
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Figure 1.  IFN-3'  induces  HIV 
expression in U1 cells. U1 cells 
were cultured in either unstimu- 
luted conditions  or with various 
concentrations  of IFN-'g. Culture 
supernatants were collected  after 
72 h stimulation  and tested  for the 
presence of R.T activity.  The re- 
suits are the average of duplicate 
samples  per each  culture  condition 
and are representative  of at least 
10 separate experiments. Similar 
results were  obtained  by determi- 
nation of the levels of HIV p24 
Ag in the culture supematants, 
using  a commercially  available 
ELISA kit (Coulter Electronics, 
Hialeah, FL). 
cumulation of all three species of HIV mRNA, including 
high levels of the unspliced 9-kb mRNA coding for gag-pol 
structural protein (Fig. 2), suggesting that IFN-'y may have 
a direct inductive effect on HIV transcription in monocytic 
cells, albeit with delayed kinetics as compared with TNF-ol 
(Fig.  2)  or PMA (data not shown). 
Results 
IFN-'y Induces HIV Expression in Chronically Infected U1 
Cells.  Stimulation of U1 cells with different concentrations 
of IFN-y (10-1,000 U/ml) induced HIV production, as mea- 
sured by RT activity in the culture superuatants, although 
to a lesser extent than did PMA stimulation (Fig. 1). Higher 
concentrations of IFN-3' (up to 5,000 U/ml) did not result 
in a significant increase of virus production as compared with 
the levels of induction observed with 500-1,000 U/ml of this 
lymphokine (data not shown). Thus, IFN-y, which has been 
previously reported to induce HIV expression in acutdy in- 
fected primary MDM (20), is another in the group of  cytokines 
capable of inducing virus expression in persistently infected 
monocytic cells  (reviewed  in reference  37).  In this regard, 
cytokines that stimulate HIV expression may induce de novo 
transcription of  viral RNAs, as demonstrated for TNF-cx and 
TNF-fl (21, 37, 39-42),  or may predominantly affect post- 
transcriptional steps in the HIV life cycle, as shown for IL-6 
(42).  We therefore investigated the effect of IFN-  T  on the 
expression of HIV RNA in U1 cells. Unstimulated U1 cells 
showed detectable levels of fully spliced 2-kb mRNA of the 
regulatory genes tat, ~  and rev (Fig. 2), as previously reported 
(40). Stimulation of U1 cells with IFN-y resulted in the ac- 
Figure 2.  fiN-'),  induces  the accumulation  of  both spliced  and unspliced 
HIV mRNAs. Total  RNA was extracted  from unstimulated  U1 cells or 
from cells stimulated  with either IFN-~/(1,000 U/ml) or TNF-ot (100 
U/ml) after 12, 24, 48, and 72 h of incubation, as described. IFN-'y  in- 
duced  significant  levels  ofHIV RNA, although  with delayed  kinetics  com- 
pared with TNF-o~-stimuhted  cells. 
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Mediated  by the Production of Endogenous  TNF-ot or TNF-~. 
The  observation  that  the  induction of steady-state  HIV 
mRNA by IFN-3' had delayed kinetics as compared with 
TNF-~ or PMA suggested the possibility that the effect of  ~  2oo 
IFN-'y could be mediated by the production of a second cel- 
lular factor. In this regard, we have previously reported that 
stimulation of U1 cells with PMA resulted in the synthesis  ~  z 
and release of TNF-ot, which actually mediated most of PMA-  ~00 
induced virus production (43). Therefore, we investigated the 
possibility that stimulation of U1 cells with IFN-3,, similar 
to PMA, triggered an autocrine pathway of viral induction  0 - 
mediated by endogenous TNF-ot or TNF-B; this possibility  0 
was also supported by the well-described  ability of IFN-3,  A 
to induce TNF production in different cell types (reviewed 
in references 1-4), including MP (44). However, in contrast 
to cells stimulated with PMA, no evidence of TNF-o~ secre- 
tion (Fig. 3 A) and/or gene transcription (data not shown) 
were obtained in U1 cells stimulated with IFN-y. Anti-TNF-ce 
and anti-TNF-/~ Ab completely suppressed the induction of  9c 
HIV expression mediated by their respective cytokine, but 
did not affect the ability of IFN-3, to induce HIV expression  ~  6c 
in U1 cells (Fig. 3 B). In addition, an anti-TNF-o~ mAb that  -~ 
significantly reduced the accumulation of HIV mRNAs in 
both TNF-c~-stimulated and PMA-stimulated U1 cells did  ~-~ 
not affect IFN-3~ induction of viral messages (data not shown).  Y- ~ 
Ultrastructural Studies of HIV Particle Synthesis  in U1 Cells  ~- o, 
Stimulated with IFN-y  in the Absence  and Presence of PMA.  ~- 
IFN-3' is a well-known activator  of MP function (1-3).  In 
addition, this lymphokine is known to exert profound effects  o 
on the differentiation of MP, including immature elements 
such as U937 promonocytic cens (the parental uninfected cell 
line of U1) (44-46). Because similar or even more profound 
effects on phagocyte activation and differentiation, as well 
as HIV expression, have been described after treatment with 
phorbol esters (46-48), we compared IFN-? and PMA with 
regard to the influence of their cellular differentiative effects 
on the process of virion maturation in U1 ceils. In this re- 
gard, we have previously described that PMA stimulation 
of U1 cells results in the rapid acquisition of the morpholog- 
ical (increased size, irregular plasma membrane, eccentric nu- 
cleus, prominent Golgi compartment, increased number of  8 
lysosomes) and functional (adherence to plastic surface, ability 
to secrete cytokines) characteristics  of differentiated  macro- 
phages (38, 43).  In addition, PMA stimulation of U1 cells 
induced budding and release of virions both at the plasma 
membrane as well as in Golgi-derived intracytoplasmic vacu- 
oles, resembling effects independently described in primary 
human macrophages infected with HIV in vitro (28-30) or 
in vivo (3I). IFN-3, stimulation of U1 cells resulted in dis- 
tinct features of cell differentiation along the MP lineage similar 
to those observed after PMA treatment (Fig. 4, A  and B). 
Furthermore, HIV particle production after IFN-3, stimula- 
tion was demonstrated both at the plasma membrane (Fig. 
4, B and C) as well as in intracytoplasmic vacuoles (Fig. 4, 
B and D). However, these features were clearly observed only 
in a fraction (<10%) of U1 cells stimulated with IFN-'y. This 
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Figure 3.  IFN-3' induction of HIV expression is not mediated by the 
secretion  of endogenous TNF-cx.  (A) PMA stimulation of U1 cells in- 
duced the secretion of detectable levels of TNF-c~, whereas no significant 
levels of this cytokine were observed in either unstimulated ceils or cells 
stimuhted with IFN-% Furthermore,  IFN-3' did not inhibit PMA-mduced 
secretion of TNF-~x (not shown). The levels of TNF-c~ present in the cul- 
ture supernatants were determined by the use of an ELISA kit (Quan- 
tikine; R & D Systems, Minneapolis, MN). (B) Effect of anti-TNF-ot mAb 
(Cutter Biological, Miles Inc., Berkeley, CA) and anti-TNlLB-neutralizing 
Ab (R & D Systems) on HIV expression in U1 cells. Anti-TNF-o~ mAb 
(1/zg/ml) and anti-TNF-B polyclonal Ab (50 ~g/ml) completely neutral- 
ized the inductive effect of TNF-c~ or TNF-15 on HIV expression, respec- 
tively, without affecting  IFN-3~-mediated upregulation of RT activity. 
742  fiN-3' Induces  Expression  of HIV in Mononuctear Phagocytes Figure 4.  IFN-7 induces HIV particle expression  and U1 cell differentiation.  (A) Transmission  electron microscopy of unstimulated U1 cells. The 
cytoplasm is dominated by ribosomes with only mattered mitochondria and profiles of rough endoplasmic reticulum and inconspicuous Golgi zones. 
(/3) A  portion of a U1 cell stimulated with IFN-'y for 72 h.  Small clusters  of virions are seen at several locations on the plasma membrane (arrow 
point to one cluster on bottom left, enlarged in C). The Golgi region is filled with vacuoles, one of which contains a mature virion (arrow, enlarged 
in D).  (A)  x4,200;  (B)  xl0,000;  (C)  x49,000;  (D)  x66,000. 
743  Biswas et al. 744  IFN-'y Induces Expression of HIV in Mononuclear Phagocytes Figure 5.  Effect  of IFN-'), and IFN-ot on PMA stimulated  U1 cells. U1 cells were stimulated  with PMA (10 -s M) either in the presence or absence 
of IFN-3' (1,000 U/m1) or IFN-ot (100 U/ml) for 48 h. Cells were then fixed and analyzed  by transmission  electron microscopy. (.4 and B) PMA 
stimulation of U1 cells induced viral particle production  both at the plasma membrane  as well as in intracytoplasmic  compartments. As compared 
with the unstimulated  U1 cells (Fig. 4 A), PMA stimulation  causes the cell to become more irregular in outline,  with an eccentric  indented  nucleus, 
and a more prominent Golgi region. Small  numbers of typical  HIV particles are seen associated  with the plasma membrane  (arrows)  and within Golgi- 
derived cytoplasmic  vacuoles,  some  of which are enlarged  in B. (C and D) IFN-3,  decreased  the levels of plasma membrane-associated  virus, but consis- 
tently increased  the intracellular  accumulation  of virions in cells stimulated  with PMA. The Golgi region  is gently  expanded  by vacuoles  containing 
HIV (several enlarged  in D). No HIV particles were detected  on the surface of this cell in this section. (E and F) IFN-ol  caused  both the accumulation 
of virions in intracelhlar  vacuoles as well as their aggregation  on the plasma membrane. A stretch of the plasma membrane  is covered  by multiple 
layers of typical HIV particles, at least two of which are in the budding stage (arrows). The Golgi region (lower right of E) is expanded  by many 
vacuoles. (A)  x9,400; (B)  x39,000; (C)  x9,700; (D)  x32,000; (E)  x,8,400; (F)  x32,000. 
is different from stimulation of  U1 with PMA in which similar 
morphological  and  functional changes  were  seen  in  the 
majority of the cells. We therefore investigated the ability 
of IFN-3' to modulate virus production in cells stimulated 
with PMA. In this regard, PMA and IFN-3, have been de- 
scribed as exerting synergistic effects on a variety of func- 
tions of MP cells, including the U937 cell line (45, 49). After 
48 h of PMA stimulation, "~50-85% of U1 cells expressed 
typical HIV particles at the plasma membrane and/or in in- 
tracytoplasmic compartments (Fig.  5, A  and B) compared 
with unstimulated cells in which virion production was es- 
sentially undetectable (Fig. 4 A). When U1 cells were stimu- 
lated with both PMA and IFN-% no changes in terms of 
the total number of ceUs expressing virus was observed. How- 
ever, costimulation with PMA and IFN-7 compared with 
stimulation with PMA alone caused a threefold decrease in 
the number of ceUs expressing HIV exclusively at the plasma 
membrane level, and a concomitant fourfold increase in cells 
in which particles  were detected only in intracytoplasmic 
vacuoles (Figs. 5, C and D, and 6 A). This effect was demon- 
strated both in terms of a shift in the proportion of ceUs with 
intravacuolar virus as well as in the total number of virions 
present within the vacuoles  (Fig.  5,  C  and D). 
IFN-T-raediated  Accumulation  of Virions  in Intracytoplasmic 
Vacuoles Results in Decreased HIV Production in PMA-stimulated 
U1 Cells.  Having established that costimulation of U1 calls 
with PMA and IFN-'), induced a redirection of the preferen- 
tial site of virus expression from the plasma membrane to 
intracytoplasmic vacuoles, we next investigated the kinetics 
of this phenomenon. A progressive increase in the levels of 
vacuole-associated  HIV particles was observed up to 5 d after 
U1 cell stimulation with either PMA or PMA plus IFN-7 
(in which cultures this phenomenon was significantly more 
pronounced) (Fig. 6 B). In contrast, a reduction of plasma- 
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Figure 6.  IFN-3' increases the intracellular accumulation  of HIV particles in PMA-stimulated U1 cells. (A) A relative increase in the percentage 
of cells exclusively showing virions budding from and contained within intracytoplasmic vacuoles was observed in cells costimulated with PMA and 
IFN-3/compared  with cells stimulated with PMA alone, as shown in Fig. 5. Results were quantified by transmission electron microscopy after 72 h 
of stimulation.  The results are representative of three independent experiments.  (B) Kinetics of virion accumulation at the plasma membrane and in 
intracytoplasmic vacuoles. The results are obtained by the analysis of the morphological features of 100 consecutive cells from one representative experi- 
ment out of three independently conducted. The simultaneous expression of virions in vacuoles and at the plasma membrane (not shown) was relatively 
stable in that it was seen in ,'o30% of U1 cells stimulated with either PMA alone or with PMA plus IFN-'y both after 3 and 5 d of culture. 
membrane associated virus was seen in ceils stimulated with 
PMA in the presence of IFN-3' as compared with cells in- 
duced by PMA alone (Fig. 6 B). Furthermore, from a kinetic 
standpoint,  virus  tended  to  accumulate over time  in  the 
vacuolar compartment as opposed to the plasma membrane 
whether cells were stimulated with PMA alone or with PMA 
plus IFN-%  This was underscored by the observation that 
lower levels of HIV were exclusively associated with the plasma 
membrane after 5 d compared with 3 d of culture regardless 
of the stimuli,  while the levels of virions segregated exclu- 
sively in vacuoles increased from day 3 to day 5 in culture 
(Fig. 6 B). We further investigated whether these morpho- 
logical changes had a functional impact on the ultimate re- 
lease of HIV from the infected cells. In this regard, we have 
previously confirmed that measurement of RT activity produc- 
tion from U1 cells (as well as other cell lines persistently in- 
fected with HIV) is a valid parameter of HIV particle release, 
in that no detectable RT activity was demonstrable in column 
fractions containing particle-free viral proteins (such as p24 
Ag) shed from infected cells (50).  A  significant decrease of 
the RT activity levels released by U1 cells stimulated with 
PMA in the presence of IFN-y was observed compared with 
cells stimulated with PMA alone (Fig.  7),  suggesting  that 
the IFN-'y-mediated redirection of virus production within 
intracytoplasmic vacuoles resulted in a relatively stable intra- 
cellular sequestration of virions throughout the culture period. 
IFN-  y Does Not Suppress the Synthesis of  HIV mRNAs and 
Proteins in PMA-stimulated Cells.  Although the uttrastruc- 
tural analysis of U1 cells stimulated with PMA in the pres- 
ence of IFN-y did not indicate that this lymphokine  had a 
suppressive effect on HIV biosynthesis, this technique allows 
one to examine only a small fraction of the total cell popula- 
tion. We therefore investigated whether the reduced levels 
of RT activity observed in PMA-stimulated cells in the pres- 
ence of IFN-3r could have been caused by reduced HIV mRNA 
and/or protein synthesis. No significant differences were ob- 
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Figure 7.  Suppressive  effect of IFN-3,  on PMA induction of ILT ac- 
tivity in U1 cell. Kinetic analysis reveals that although IFN-3~ alone in- 
duces RT activity in U1 cells,  the stimulation with PMA  and IFN-'y 
markedly suppresses the induction of RT activity compared with stimula- 
tion with PMA alone. 
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tive slot-blot analysis (Fig. 8 A). Furthermore, no significant 
changes in the relative or absolute levels of spliced and un- 
spliced HIV mRNAs were seen by Northern blot analysis 
of these cells (data not shown). A modest increase in the levels 
of ceil-associated  HIV proteins was observed in U1 cells stimu- 
lated with PMA plus IFN-? as compared with cells activated 
with PMA alone, likely resulting from the independent in- 
ductive effect of these two agents (Fig.  8 B), and/or from 
the increased accumulation of vacuole-associated HIV parti- 
cles in cells costimulated with PMA and IFN-~ (Figs. 5 and 
6). Finally, cell disruption by multiple cycles of freezing and 
thawing resulted in the recovery of RT levels from U1 cells 
costimulated with PMA and IFN-3' to the levels  of  cells stimu- 
lated with PMA alone (data not shown), indicating that the 
reduced levels of supernatant-associated  RT activity were not 
a consequence of decreased virus expression, but resulted from 
the accumulation of particles in intracellular compartments. 
The Decrease in PMA-induced Virus Production in UI  Cells 
Stimulated with IFN-  7 Is Not Mediated by Secretion of  Endoge- 
nous IFN-a/~.  We and others have  previously described that 
IFN-a could suppress the production of RT activity in per- 
sistently infected T lymphocytic cell lines as a consequence 
of a block in the release of HIV particles  from the plasma 
membrane and in the absence of a suppressive effect on HIV 
protein synthesis (33-35).  To investigate whether the reduced 
production of HIV particles  in the culture supernatant ob- 
served in ceils stimulated with PMA in the presence of IFN-3, 
was a consequence of endogenously  produced IFN-c~, we com- 
pared the effect of IFN-tx with that of IFN-3' in U1 ceils 
stimulated with PMA at the ultrastructural level. Similar to 
IFNw, IFN-a increased the intracdlular accumulation of virus 
particles in PMA-stimulated U1 ceils (Fig. 5, E and F). How- 
ever, unlike IFN-% which decreased the quantity of plasma 
membrane-associated virus, IFN-ot caused the clustering of 
virions at the external plasma membrane (postbudding effect), 
as previously described in several infected T lymphocytic  cell 
lines (33-35). Both IFN-tx and IFN-'y inhibited P/viA-induced 
virus expression, although IFN-tx was consistently more po- 
tent in this regard than IFN-'y (Fig. 9). Anti-IFN-ct Ab com- 
pletely restored the levels of RT activity in the culture super- 
natants of cells stimulated with PMA plus IFN-a to the levels 
observed in cells stimulated with PMA alone, whereas it did 
not affect the suppressive effect of IFN-3' (Fig.  9).  Similar 
results were observed in U1 cells incubated under these con- 
ditions for longer times, and in experiments using rlFN-fl 
and anti-IFN-fl-nentralizing Ab (data not shown), indicating 
that the suppressive effects of IFN-'y on RT production in 
PMA-stimulated U1 cells were not mediated by IFN-ot or 
IFN-fl. Of note is the fact that no inductive effects on HIV 
expression were seen in U1 ceils treated with IFN-oe alone 
(or IFN-fl alone; data not shown), in contrast to cells stimu- 
lated with IFN-% 
Discussion 
In the present study we have demonstrated that IFN-v is 
a direct inducer of HIV expression in persistently infected 
promonocytic U1 cells. The effect of IFN-3~ was correlated 












Figure 8.  IFNw does not reduce the levels  of PMA-induced  HIV mRNA 
or proteins. (,4) Slot-blot analysis  ofHIV RNA. Total RNA was e:~tracted 
from either unstimulated U1 cells or from calls stimulated with PMA or 
PMA plus IFN-'), for 24 h, and was diluted in a slot-blot apparatus. Northern 
blot analysis confirmed that IFN-? did not reduce PMA-induced accumu- 
lation of spliced and unspliced HIV mRNAs. (/3)  Direct induction  of HIV 
protein synthesis  in  U1 ceils  stimulated with IFN-'y  alone and lack of  IFN-"/ 
inhibition  of PMAqnduced viral proteins. The results represent the levels 
of cell-associated HIV proteins  present  after 48 h incubation and were 
confirmed by analyses performed  at both earlier (24 h) and later (72 h) 
times after stimulation. 
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Figure 9.  IFN-3' inhibition  of PMA-induced  HIV expression  is not medi- 
ated by the release of endogenous IFN-tx. U1 cells were stimulated with 
PMA in the presence or absence of IFN-ot or IFN-% either alone or in 
combination  with various concentrations of a sheep anti-IFN-tx polydonal 
Ab (Interferon Sciences, Inc., New Brunswick, NJ). The results refer to 
the levels of RT activity detected after 48 h of incubation, when the in- 
ductive effect of IFN-'/alone  was not yet detectable. No effect of the anti- 
IFN-a Ab was seen on cells treated with PMA plus IFN-'), even at later 
time points. with the accumulation of spliced and unspliced HIV mRNAs 
as well as with viral protein synthesis. In addition,  IFN-qr 
induced the differentiation of U1 cells along the MP lineage 
in association with features of intracytoplasmic HIV accumu- 
lation in Golgi-derived vacuoles. Furthermore, IFN-qr greatly 
enhanced the intracellular  accumulation of HIV concomi- 
tant  with  a  significant  reduction of plasma  membrane- 
associated virions in U1 cells costimulated with PMA, a po- 
tent  inducer of both  HIV transcription  and macrophage 
differentiation. 
Several cytokines have been described as being capable of 
either upregulating (i.e., 11,2, I1,3, I1,6, M- and GM-CSF, 
and TNF-odB), suppressing (i.e., IFN-odB), or exerting mul- 
tiple and opposite effects (TGF-B and I1,4) on HIV expres- 
sion (reviewed  in references  21 and 37). With regard to IFN-3', 
Koyanagi et al. (20) observed that stimulation of MDM with 
this lymphokine before infection induced viral replication, 
whereas IFN-y treatment of previously infected MDM re- 
duced HIV expression; however, no explanation for this func- 
tional  dichotomy was provided,  and different results were 
reported by other investigators (19). In the persistently in- 
fected U1 cells employed in the present study, we have inves- 
tigated by both functional and ultrastructural studies the pat- 
terns of virus production after stimulation with IFN-3' alone 
or after costimulation with IFN-3/and PMA. The direct in- 
ductive effect of IFN-'y on HIV expression was correlated 
with cell differentiation and the appearance of virions in in- 
tracellular vacuoles, although these features  were clearly  present 
only in a minority of the cell population. In PMA-stimulated 
ceils, IFN-3, caused a significant inhibition of  virion-associated 
RT activity released into the culture supernatant as compared 
with cells stimulated with PMA alone. However, this effect 
was not explained by either a reduced synthesis of viral pro- 
teins or RNA. When the functional and morphological effects 
of IFN-3' were compared with those of IFN-ot, we observed 
that both IFNs modulated virus production in persistently 
infected cells stimulated with PMA by either inhibiting the 
ability of the virus to be released from the plasma membrane 
(as previously seen in IFN-ot-treated T lymphocytic  cells and 
here demonstrated in monocytic U1 cells) or by causing an 
accumulation of virions in intracdlular vacuoles  (as here shown 
in U1 cells treated with either IFN-cz or IFN~). These results 
suggest that the capability of IFN-3' to shift the preferential 
morphological site of  virus maturation from the plasma mem- 
brane to the intracellular compartment leads to an apparent 
decrease in particle release, which in reality is a diversion of 
virion production resulting in a relatively stable intracdlular 
viral reservoir. In this regard, we have previously described 
that long-term in vitro cultures  of bone marrow-derived 
human macrophages infected in vitro with HIV-1 contained 
abundant levels of vacuole-associated particles after several 
weeks of culture (51). lZurthermore, other investigators have 
observed virus accumulation  in intracellular compartments 
as well as liberation of substantial RT activity after cell dis- 
ruption after several  days of  culture of  primary infected MDM 
(28-30,  32). Finally, vacuole-associated HIV has also been 
described in the brain macrophages of HIV-infected individ- 
uals (31). The potential role of IFN-3' as an in vivo mediator 
of intracellular accumulation of virus particles in monocytes 
and macrophages of HIV-infected individuals remains to be 
established. However, the observation  of elevated levels of 
IFN-3, (or of its related marker neopterin) in the plasma and 
CSF (5-7) as well as in the lymph nodes of HIV-infected in- 
dividuals (12), where the number of infected cells actively 
expressing HIV is much higher compared with the periph- 
eral blood compartment (52-54),  suggests that IFN-3' may 
play a role in the in vivo regulation of HIV expression. 
Although IFN-qr and TNF-ot have now been clearly  demon- 
strated to induce HIV expression  in a variety of model systems, 
including I1,2-stimulated PBMC (14), earlier studies had in- 
dicated the possibility that these two cytokines, either alone 
or in combination, could exert some suppressive effect on 
virus replication (15). In addition, IFN~ restored certain defec- 
tive functions in vitro, such as the natural killer cell activity 
in PBMC of HIV-infected individuals (10, 55). Based on these 
and other observations (15-19), IFN-3, has been employed 
as a therapeutic agent both in the treatment of HIV infec- 
tion and of AIDS-associated Kaposi's sarcoma (reviewed in 
references  56 and 57) with conflicting results. In some studies 
reduction of plasma levels of p24 Ag, improvement of im- 
mune function, and clinical course have been described (58), 
whereas exacerbation and progression of  disease have also been 
reported (59). Our in vitro findings suggest that the induc- 
tive effects of IFN-3' on HIV-infected MP are complex and 
that the apparent suppressive effects on virus production may 
in fact represent merely a diversion of the preferential sub- 
cellular site of virion production from the plasma membrane 
to intracytoplasmic  vacuoles. In addition,  we have clearly 
demonstrated that IFN-3' alone can upregulate HIV expres- 
sion in persistently infected MP cells. Thus, caution should 
be used in the &sign of therapeutic strategies involving IFN-~/ 
as potential  antiviral agent. 
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